CK0802: meta-analysis of COVID-19 studies

All studies   Mortality   Serious outcomes   RCTs   RCT mortality   Peer-reviewed   All outcomes  
Meta-analysis1 study · 30 patientsc19early.org

CK0802 for COVID-19

Serious outcome risk
CK0802
Control
Outcome (studies)
Improvement
Relative risk · 95% CI
All studies (1)−8%
Mortality (1)−8%
RCTs (1)−8%
Late (1)−8%
00.511.5+
← CK0802
reduces riskIncreased
risk →
c19early.org
October 2026

CK0802 COVID-19 studies

StudyImprovementRR · 95% CIOutcomeTreatmentControlRelative Risk
Gladstone (DB RCT)−8%1.08 · 0.33–3.57death15 (n)15 (n)
Late treatment−8%1.08 · 0.33–3.5715 (n)15 (n)8% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.91
All studies−8%1.08 · 0.33–3.5715 (n)15 (n)8% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.9100.511.52+
Rotate screen for more detailsIncrease width for more details
← CK0802
reduces riskCK0802
increases risk →
c19early.org
October 2026

CK0802 COVID-19 mortality results

StudyImprovementRR · 95% CITreatmentControlRelative Risk
Gladstone (DB RCT)−8%1.08 · 0.33–3.5715 (n)15 (n)
Late treatment−8%1.08 · 0.33–3.5715 (n)15 (n)8% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.91
All studies−8%1.08 · 0.33–3.5715 (n)15 (n)8% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.9100.511.52+
Rotate screen for more detailsIncrease width for more details
← CK0802
reduces riskCK0802
increases risk →
c19early.org
October 2026

CK0802 COVID-19 serious outcomes

StudyImprovementRR · 95% CIOutcomeTreatmentControlRelative Risk
Gladstone (DB RCT)−8%1.08 · 0.33–3.57death15 (n)15 (n)
Late treatment−8%1.08 · 0.33–3.5715 (n)15 (n)8% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.91
All studies−8%1.08 · 0.33–3.5715 (n)15 (n)8% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.9100.511.52+
Rotate screen for more detailsIncrease width for more details
← CK0802
reduces riskCK0802
increases risk →
c19early.org
October 2026

CK0802 COVID-19 Randomized Controlled Trials

StudyImprovementRR · 95% CIOutcomeTreatmentControlRelative Risk
Gladstone (DB RCT)−8%1.08 · 0.33–3.57death15 (n)15 (n)
Late treatment−8%1.08 · 0.33–3.5715 (n)15 (n)8% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.91
All studies−8%1.08 · 0.33–3.5715 (n)15 (n)8% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.9100.511.52+
Rotate screen for more detailsIncrease width for more details
← CK0802
reduces riskCK0802
increases risk →
c19early.org
October 2026

CK0802 COVID-19 RCT mortality results

StudyImprovementRR · 95% CITreatmentControlRelative Risk
Gladstone (DB RCT)−8%1.08 · 0.33–3.5715 (n)15 (n)
Late treatment−8%1.08 · 0.33–3.5715 (n)15 (n)8% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.91
All studies−8%1.08 · 0.33–3.5715 (n)15 (n)8% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.9100.511.52+
Rotate screen for more detailsIncrease width for more details
← CK0802
reduces riskCK0802
increases risk →
c19early.org
October 2026

CK0802 COVID-19 peer reviewed studies

StudyImprovementRR · 95% CIOutcomeTreatmentControlRelative Risk
Gladstone (DB RCT)−8%1.08 · 0.33–3.57death15 (n)15 (n)
Late treatment−8%1.08 · 0.33–3.5715 (n)15 (n)8% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.91
All studies−8%1.08 · 0.33–3.5715 (n)15 (n)8% higher risk
Tau² = 0.00, I² = 0.0%, p = 0.9100.511.52+
Rotate screen for more detailsIncrease width for more details
← CK0802
reduces riskCK0802
increases risk →
c19early.org
October 2026

CK0802 COVID-19 outcomes

StudyImprovementRR · 95% CIOutcomeTreatmentControlRelative Risk
Gladstone (DB RCT)−8%1.08 · 0.33–3.57death15 (n)15 (n) Gladstone (DB RCT)−75%1.75 · 0.64–4.75death7/154/15 Gladstone (DB RCT)50%0.50 · 0.11–2.33death2/154/15 Gladstone (DB RCT)−27%1.27 · 0.72–2.23death/int.15 (n)15 (n) Gladstone (DB RCT)−50%1.50 · 0.71–3.16death/int.9/156/15 Gladstone (DB RCT)0%1.00 · 0.42–2.40death/int.6/156/15
00.511.52+
Rotate screen for more detailsIncrease width for more details
← CK0802
reduces riskCK0802
increases risk →